Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant infectious laryngotracheitis virus and uses thereof

Recombinant infectious laryngotracheitis virus and uses thereof

US Patent 7501491 · Granted Mar 10, 2009

Estimated economic value: $203,628,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Feline CD86 polypeptides and nucleic acids2011
Recombinant attenuated clostridium organisms and vaccine2011
Neutralizing GDF8 epitope-based growth enhancing vaccine2011
Recombinant infectious laryngotracheitis virus and uses thereof2011
Recombinant infectious laryngotracheitis virus and uses thereof2011
Phagemid vectors2011
Recombinant attenuated Clostridium organisms and vaccine2010
Feline CTLA-4 nucleic acid and polypeptides2010
Recombinant attenuated clostridium organisms and vaccine2010
Nucleic acids encoding neutralizing GDF8 epitope-based peptides and fusion prote2009
Plant virus coat fusion proteins with GDF8 epitopes and vaccines thereof2008
Neutralizing GDF8 epitope-based growth enhancing vaccine2008